The program objective is to train promising new scientists in mechanisms of cardiovascular diseases, experimental strategies and technologies necessary for development of novel molecular therapeutics. The theme of the program is signal transduction within a multidisciplinary, integrated program that focuses on moleculareventsincardiovasculardevelopment,proteomics,cardiacstemcellsandregenerativemedicineas well as the molecular basis of cardiovascular disease. Future decades will see rapid advances in our understandingofthestructureandfunctionofmoleculesinvolvedincardiovasculardiseaseandhopefullythe successful application of these insights into the development of novel treatments and prevention of cardiovasculardiseases.Suchadvanceswillrequirewell-trained,energeticandproductivescientistswiththe ability to understand and manipulate molecular events within a physiological context. These are the type of individuals that we intend to develop through the integrated predoctoral and postdoctoral components of this training program. The 29 mentor-eligible faculty members were selected on the basis of their research interests related to cardiovascular diseases, active NIH research support, ongoing collaborations, successful training and mentoring experience, and commitment to predoctoral and postdoctoral training. The Program Director and Associate Director are assisted by a Program Steering Committee and an External Advisory Committee of outstanding experts in the field of cardiovascular biology. Key components of the training program are the mentor research experience, required didactic courses providing a broad perspective of cardiovasculardisease,requiredtrainingandresponsibleconductofresearch,electivecourses,cardiovascular journal club, seminars, presentations at regional and national conferences, and professional development activities. The cardiovascular courses, journal club, seminars, workshops, student research day, and annual cardiovascular retreat provide a framework for all trainees to interact, collaborate, and work together during theirtrainingexperience.Anintegrative,multi-yearevaluationplanisusedtomeasuretheextenttowhichthe program goals and objectives are met.
Our aim i s to produce outstanding investigators with a broad insight intocardiovasculardysfunctionwhomakesignificantcontributionstotheunderstandingofthesedisordersand developmentoftherapiesforcardiovasculardiseases.

Public Health Relevance

/PUBLICHEALTHRELEVANCE The need for a highly trained workforce to address the treatment of cardiovascular disease continues to increase. Major demographic changes resulting from an aging population, elderly with chronic disease, and obesity are leading to increases in risk for cardiovascular events;? interventional therapies and increasing survivalratesarerequiringmorespecializedtreatmentsandfollow-ups;?andnewtechnologiesmethodologies are requiring additional training in sophisticated procedures. This training grant will help train the next generationofscientistsandclinicianscientistsengagedincardiovascularresearch.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007260-44
Application #
9962440
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Wang, Wayne C
Project Start
1977-07-01
Project End
2022-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29407
Wright, Lillianne H; Herr, Daniel J; Brown, Symone S et al. (2018) Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling. JCI Insight 3:
Herr, Daniel J; Baarine, Mauhamad; Aune, Sverre E et al. (2018) HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury. J Mol Cell Cardiol 114:309-319
Stephenson, Sarah E; Wilson, Carole L; Crothers, Kristina et al. (2018) Impact of HIV infection on ?1-antitrypsin in the lung. Am J Physiol Lung Cell Mol Physiol 314:L583-L592
Kimbrough, Denise; Wang, Sabina H; Wright, Lillianne H et al. (2018) HDAC inhibition helps post-MI healing by modulating macrophage polarization. J Mol Cell Cardiol 119:51-63
Cheng, Qi; Patel, Kunal; Lei, Biao et al. (2018) Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant. Am J Transplant 18:2417-2428
Tran, Danh T; Esckilsen, Scott; Mulligan, Jennifer et al. (2018) Impact of Mitochondrial Permeability on Endothelial Cell Immunogenicity in Transplantation. Transplantation 102:935-944
Richards, Dylan; Jia, Jia; Yost, Michael et al. (2017) 3D Bioprinting for Vascularized Tissue Fabrication. Ann Biomed Eng 45:132-147
Richards, Dylan J; Coyle, Robert C; Tan, Yu et al. (2017) Inspiration from heart development: Biomimetic development of functional human cardiac organoids. Biomaterials 142:112-123
Toomer, Katelynn A; Fulmer, Diana; Guo, Lilong et al. (2017) A role for primary cilia in aortic valve development and disease. Dev Dyn 246:625-634
Tan, Yu; Richards, Dylan; Coyle, Robert C et al. (2017) Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids. Acta Biomater 51:495-504

Showing the most recent 10 out of 123 publications